Literature DB >> 25298828

Examination of clinical efficacy of keishibukuryogan on non-specific complaints associated with varicose veins of the lower extremity.

Shinobu Hayashi1, Shintaro Shibutani1, Hirotoki Okubo1, Tatsuya Shimogawara1, Tsuyoshi Ichinose1, Yasuhiro Ito1, Kouki Mihara1, Tomohisa Egawa1, Atsushi Nagashima1, Hideaki Obara2, Yuko Kitagawa2.   

Abstract

The subjective symptoms of varicose veins of the lower extremity often include malaise, numbness, coldness, pain, and pruritus of the lower extremity, and relieving these complaints is important in managing the quality of life of patients. We have examined the clinical efficacy of keishibukuryogan, a Kampo prescription for improving oketsu (impaired microcirculation, congestion), on non-specific complaints associated with varicose veins of the lower extremity. Keishibukuryogan was administered to 30 patients with non-specific complaints associated with varicose veins of the lower extremity for 12 weeks, resulting in improvements in the scores of subjective symptoms, severity of varicose veins, and oketsu as well as an increase in skin perfusion pressure. And especially the effect was remarkable in female. In addition, oketsu was shown to be involved in the subjective symptoms associated with varicose veins of the lower extremity, demonstrating efficacy of keishibukuryogan. No adverse drug reaction or abnormal laboratory result was observed in patients receiving keishibukuryogan, and the rate of general improvement and usefulness was 73.3%. It was suggested that keishibukuryogan was useful to improve the symptoms of patients with non-specific complaints associated with varicose veins of the lower extremity especially in female patients. (English translation of Jpn J Phlebol 2013; 24: 303-310).

Entities:  

Keywords:  Kampo prescription; keishibukuryogan; non-specific complaints; oketsu; varicose veins of the lower extremity

Year:  2014        PMID: 25298828      PMCID: PMC4180688          DOI: 10.3400/avd.oa.14-00055

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  6 in total

1.  Effects of a Chinese herbal medicine, keishi-bukuryo-gan, on the gonadal system of rats.

Authors:  S Sakamoto; H Kudo; T Kawasaki; K Kuwa; N Kasahara; S Sassa; R Okamoto
Journal:  J Ethnopharmacol       Date:  1988 Jul-Aug       Impact factor: 4.360

2.  [Effects of anti-"Oketsu" drugs on blood coagulation and fibrinolysis].

Authors:  K Terasawa; M Kimura; N Sakuragawa; Y Uchiyama; K Toriizuka; M Ueno; I Horikoshi
Journal:  Yakugaku Zasshi       Date:  1983-03       Impact factor: 0.302

Review 3.  Revision of the CEAP classification for chronic venous disorders: consensus statement.

Authors:  Bo Eklöf; Robert B Rutherford; John J Bergan; Patrick H Carpentier; Peter Gloviczki; Robert L Kistner; Mark H Meissner; Gregory L Moneta; Kenneth Myers; Frank T Padberg; Michel Perrin; C Vaughan Ruckley; Philip Coleridge Smith; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2004-12       Impact factor: 4.268

4.  Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats.

Authors:  H Goto; Y Shimada; N Sekiya; Q Yang; T Kogure; N Mantani; H Hikiami; N Shibahara; K Terasawa
Journal:  Phytomedicine       Date:  2004-02       Impact factor: 5.340

5.  Efficacy of keishibukuryogan, a traditional Japanese herbal medicine, in treating cold sensation and numbness after stroke: clinical improvement and skin temperature normalization in 22 stroke patients.

Authors:  Keishi Fujita; Tetsuya Yamamoto; Takao Kamezaki; Akira Matsumura
Journal:  Neurol Med Chir (Tokyo)       Date:  2010-01       Impact factor: 1.742

6.  Comparative efficacy of Keishi-bukuryo-gan and pentoxifylline on RBC deformability in patients with "oketsu" syndrome.

Authors:  H Hikiami; H Goto; N Sekiya; N Hattori; I Sakakibara; Y Shimada; K Terasawa
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

  6 in total
  6 in total

1.  Keishibukuryogan, a Traditional Japanese Medicine, Inhibits Platelet Aggregation in Guinea Pig Whole Blood.

Authors:  Kiyoshi Terawaki; Masamichi Noguchi; Mitsutoshi Yuzurihara; Yuji Omiya; Yasushi Ikarashi; Yoshio Kase
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

Review 2.  A Review on the Mechanism and Application of Keishibukuryogan.

Authors:  Koichiro Tanaka; Koki Chiba; Kazuhiko Nara
Journal:  Front Nutr       Date:  2021-12-24

Review 3.  The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.

Authors:  Jie Gao; Jianmei Yang; Zhiyuan Lu; Xianwen Dong; Ying Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-29       Impact factor: 2.650

4.  The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark.

Authors:  Naohiro Iwata; Mosaburo Kainuma; Daisuke Kobayashi; Toshio Kubota; Naoko Sugawara; Aiko Uchida; Sahoko Ozono; Yuki Yamamuro; Norihiro Furusyo; Koso Ueda; Eiichi Tahara; Takao Shimazoe
Journal:  Front Pharmacol       Date:  2016-06-20       Impact factor: 5.810

5.  Observational Study of the Association Between Tongue Exam and the Kampo Diagnostic Procedure of Fuku Shin (Abdominal Exam) in Blood Stasis.

Authors:  Young-Chang Arai; Shuichi Aono; Izumi Makino; Makoto Nishihara; Tatsunori Ikemoto; Keiko Owari
Journal:  J Evid Based Complementary Altern Med       Date:  2017-07-03

6.  Effective Use of Keishibukuryogan in Subcutaneous Hematoma after Implantable Cardiac Device Surgery in Two Cases.

Authors:  Jun Kumanomido; Masatsugu Ohe; Ryo Shibata; Yuichi Hattori; Yuta Ishizaki; Shogo Ito; Yume Nohara; Jinya Takahashi; Kensuke Hori; Aya Obuchi; Masanori Ohtsuka; Yoshihiro Fukumoto
Journal:  Intern Med       Date:  2020-10-07       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.